Literature DB >> 11085957

Efficacy and safety of an irrigated-tip catheter for the ablation of accessory pathways resistant to conventional radiofrequency ablation.

T Yamane1, P Jaïs, D C Shah, M Hocini, J T Peng, I Deisenhofer, J Clémenty, M Haïssaguerre.   

Abstract

BACKGROUND: Radiofrequency catheter ablation of accessory pathways (APs) is very effective in all but a minority of patients. We examined the usefulness and safety of irrigated-tip catheters in treating patients with APs resistant to conventional catheter ablation. METHODS AND
RESULTS: Among 314 APs in 301 consecutive patients, conventional ablation failed to eliminate AP conduction in 18 APs in 18 patients (5.7%), 6 of which were located in the left free wall, 5 in the middle/posterior-septal space, and 7 inside the coronary sinus (CS) or its tributaries. Irrigated-tip catheter ablation was subsequently performed with temperature control mode (target temperature, 50 degrees C), a moderate saline flow rate (17 mL/min), and a power limit of 50 W (outside CS) or 20 to 30 W (inside CS) at previously resistant sites. Seventeen of the 18 resistant APs (94%) were successfully ablated with a median of 3 applications using irrigated-tip catheters. A significant increase in power delivery was achieved (20.3+/-11.5 versus 36.5+/-8.2 W; P:<0.01) with irrigated-tip catheters, irrespective of the AP location, particularly inside the CS or its tributaries. No serious complications occurred.
CONCLUSIONS: Irrigated-tip catheter ablation is safe and effective in eliminating AP conduction resistant to conventional catheters, irrespective of the location.

Entities:  

Mesh:

Year:  2000        PMID: 11085957     DOI: 10.1161/01.cir.102.21.2565

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

1.  Implications of cavotricuspid isthmus block complicating ablation of a posteroseptal accessory pathway.

Authors:  Leonard Ilkhanoff; Luis F Couchonnal; Jeffrey J Goldberger
Journal:  J Interv Card Electrophysiol       Date:  2012-05-15       Impact factor: 1.900

Review 2.  Optimal ablation strategies for different types of ventricular tachycardias.

Authors:  Takumi Yamada; G Neal Kay
Journal:  Nat Rev Cardiol       Date:  2012-05-29       Impact factor: 32.419

3.  Ablation of difficult right-sided accessory pathways aided by mapping of tricuspid annular activation using a Halo catheter : Halo-mapping of right sided accessory pathways.

Authors:  Tom Wong; Wajid Hussain; Vias Markides; Diana A Gorog; Ian Wright; Nicholas S Peters; D Wyn Davies
Journal:  J Interv Card Electrophysiol       Date:  2006-11-18       Impact factor: 1.900

4.  A novel technique for zero-fluoroscopy catheter ablation used to manage Wolff-Parkinson-White syndrome with a left-sided accessory pathway.

Authors:  Gunter Kerst; Ulli Parade; Hans-Jörg Weig; Michael Hofbeck; Meinrad Gawaz; Jürgen Schreieck
Journal:  Pediatr Cardiol       Date:  2012-02-25       Impact factor: 1.655

5.  A subvalvular catheter approach for radiofrequency ablation of right-sided accessory pathways.

Authors:  Marcus Wieczorek; Sharam Tajtaraghi; Reinhard Hoeltgen
Journal:  J Interv Card Electrophysiol       Date:  2019-08-05       Impact factor: 1.900

6.  Factors influencing lesion formation during radiofrequency catheter ablation.

Authors:  Olaf J Eick
Journal:  Indian Pacing Electrophysiol J       Date:  2003-07-01

7.  Quantification of irrigated lesion morphology using near-infrared spectroscopy.

Authors:  Soo Young Park; Rajinder Singh-Moon; Haiqiu Yang; Deepak Saluja; Christine Hendon
Journal:  Sci Rep       Date:  2021-10-11       Impact factor: 4.379

8.  Establishing Safe Working Parameters for Radiofrequency Ablation In Vitro Using Acoustic Sensing, Probability Mapping, and Catheter Contact Angle.

Authors:  Wadih El Khoury; Joseph Al Aaraj; Anthony Gebran; Marwan Hajjar; Rawad Abbas; Hussein Daoud; Maurice Khoury; Bernard Abi-Saleh; Ghanem F Oweis; Marwan M Refaat
Journal:  J Innov Card Rhythm Manag       Date:  2022-07-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.